impahctstudy.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Aerovate Therapeutics IMPAHCT Study for |
| Description | IMPAHCT: Looking for a new way to treat Pulmonary Arterial Hypertension Dry powder inhaled imatinib clinical trial IMPAHCT study – looking for a new way to treat Pulmonary Arterial Hypertension |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.162.107.11 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
impahctstudy.com Valuation
|
US$522,077
Last updated: 2023-05-19 19:47:18
impahctstudy.com has Semrush global rank of 20,273,479. impahctstudy.com has an estimated worth of US$ 522,077, based on its estimated Ads revenue. impahctstudy.com receives approximately 60,240 unique visitors each day. Its web server is located in United States, with IP address 52.162.107.11. According to SiteAdvisor, impahctstudy.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$522,077 |
| Daily Ads Revenue | US$482 |
| Monthly Ads Revenue | US$14,458 |
| Yearly Ads Revenue | US$173,490 |
| Daily Unique Visitors | 4,016 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| impahctstudy.com. | A | 3600 | IP: 52.162.107.11 |
| impahctstudy.com. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
| impahctstudy.com. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
| impahctstudy.com. | TXT | 3600 | TXT Record: lr8jc5i4llfghfnksle8in2k13 |
HtmlToTextCheckTime:2023-05-19 19:47:18
| FOR PATIENTS FOR HEALTHCARE PROFESSIONALS IMPAHCT: Looking for a new way to treat Pulmonary Arterial Hypertension (PAH) The IMPAHCT Study is investigating a potential new medication (an “investigational medication”) for PAH. The study aims to find out which dose, or strength, of the investigational medicine is safe and tolerable, and works best in people with PAH. Researching new treatment options Current drugs for PAH help relieve symptoms like fatigue and shortness of breath but fail to treat the underlying cause of the disease. Aerovate Therapeutics is aiming to change the way PAH is treated. They are currently researching a targeted investigational therapy that is designed to relieve the symptoms of PAH and address an underlying cause of the disease. What is PAH? PAH is a rare and serious disease that affects more women than men (about 65–80% of patients), with the average age of those affected being around 50. In PAH, blood vessels in your lungs have thickened and narrowed due to |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 15 Nov 2022 08:40:31 GMT Location: https://impahctstudy.com/ HTTP/1.1 200 OK Content-Length: 19269 Content-Type: text/html Date: Tue, 15 Nov 2022 08:40:32 GMT Server: nginx/1.22.0 Accept-Ranges: bytes ETag: "62a3540a-4b45" Last-Modified: Fri, 10 Jun 2022 14:24:10 GMT |
impahctstudy.com Whois Information
Domain Name: IMPAHCTSTUDY.COM Registry Domain ID: 2689088916_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-09-30T16:39:00Z Creation Date: 2022-04-13T18:26:13Z Registry Expiry Date: 2025-04-13T18:26:13Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-15T08:41:04Z <<< |